04 Nov 2011

1st Scientific & Industrial Committee – ACCELENCE Bordeaux Clinical Research Network

On September 9th 2011, ACCELENCE BORDEAUX CLINICAL RESEARCH NETWORK (BCRN) held the first Scientific & Industrial Committee at the Bordeaux Chamber of Commerce and Industry.

40 industry representatives (of wich 11 large pharmaceutical laboratoires and 4 international CROs), 30 key opinion leaders in numerous fields of expertise as well as dozen delegates from innovation support organizations attended this event, and event that also marked the launch and recognition of a first in public/private partnerships in Europe, an organizational innovation serving scientific and medical innovation.

On the same occasion, ACCELENCE BCRN, its founding members and QUINTILES signed a “PRIME SITE” partnership-agreement.

Mot clés : , , , , , , , , , , , , , , , , , , , , , | Read
12 Oct 2011

Partnerships in Clinical Trials, Lyon – France

Mot clés : , , , , , , , , , , , , , , , , | Read
12 Oct 2011

Bordeaux University awarded the “Initiative for Excellence”

Reference: University of Bordeaux, March 25th 2011

In July 2011, the Bordeaux Segalen University was awarded the national call for projects « Initiative for excellence » and obtained significant funding for the setup of a Hospital/University Institute dedicated to electrical cardiac diseases, two laboratories for excellence in the fields of inter- and multidisciplinary research in bio-imaging and neuroscience and an infrastructure for cellular photonic and electronic bio-imaging.

Mot clés : , , , , , , , , , , , , , , , , | Read
12 Oct 2011

The Biomaterials CIC-IT, innovation for the benefit of patients

Source: Recherches CHU Bordeaux N°5, the Bordeaux University Hospital’s six-monthly newsletter on clinical research, September 2010

The Bordeaux University Hospital has collaborated with Inserm and the Bordeaux Segalen University to efficiently structure the transfer of technological innovation in the field of biomaterials. The result obtained following the latest Inserm/Ministry of Health evaluation, performed at the end of 2009, is a reward for the work carried out as well as strong encouragement for the future.

Mot clés : , , , , , , , , , , , , , , , , | Read
12 Oct 2011

Tissue Microarray Cytometry Reveals Positive Impact of Homeodomain Interacting Protein Kinase 2 in Colon Cancer Survival Irrespective of p53 Function

Source: Fluofarma website

Mot clés : , , , , , , , , , , , , , , , , | Read